- Home
- Industry Reports
- Biotechnology
- Healthcare
- North America Proteomics Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Proteomic is a massive study of proteins of their function and structure of proteome. A proteome is set of proteins produced in an organism which differs from one cell to another cell and changes over time. North America Proteomics Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of XX% to reach USD XX billion by 2024.
North America Proteomics Market Share:
Proteomics market is segmented by technology, services, application, and geography. On basics of technology, the most substantial share is in North America due to the increasing demand for targeted diagnosis and treatment for the betterment of the medical facilities.
North America Proteomics Market Size:
The capacity of microarrays to provide more information from less number of samples, and treating diseases like obesity and cancer has driven the marketplace for proteomics in North America. In the U.S., protein microarray has demand in the market, for about half the market.
North America Proteomics Market Growth:
The market for proteomics are driven by factors such as genetic disorders, pharmaceutical, biopharmaceutical market, advancement in technology, and customised medicines are reasons for the overall growth of the North America proteomics market.
North America Proteomics Market Industrial Analysis:
North America Proteomics Market is segmented by technology, services, applications, and geography. In this classification, the growth of the market is driven by technology segment classified by chromatography, X-Ray crystallography, protein microarray, and spectroscopy. In the forecast period, Asia-Pacific is expected to grow at a quick pace for proteomics technologies.
North America Proteomics Market Outlook:
Proteomics is primarily used to treat the genetic disorders, obesity, cancer and increase in demand for the pharmaceutical research, increased investment by the government for R&D in proteomics, healthcare and drug development further increased the demand for proteomics across various verticals and it’s predominant in North America especially the US.
North America Proteomics Market Trends:
Caprion Bioscience Inc., along with the Foundation for the National Institutes of Health Biomarkers Consortium has come up with the Cerebrospinal Fluid Proteomics project in August 2017.
GE Healthcare Inc., providers of science and medical products, has acquired Puridify Inc., in November 2017.
North America Proteomics Market Research Reports:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Caprion Proteomics Inc.
- PerkinElmer, Inc.
- Bruker Corporation
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Protein Microarray
6.2 X-Ray Crystallography
6.3 Chromatography
6.4 Spectroscopy
Chapter 7 Market Segmentation by Services
7.1 Quantitation Services
7.2 Data Analysis & Maintenance
7.3 Analytical Laboratory Services
Chapter 8 Market Segmentation by Application
8.1 Drug Discovery
8.2 Clinical Diagnosis
8.3 Others
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Genzyme Corporation
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Caprion Proteomics Inc.
11.3 PerkinElmer, Inc.
11.4 Bruker Corporation
11.5 Danaher Corporation
11.6 Bio-Rad Laboratories, Inc.
11.7 Luminex Corporation
11.8 Agilent Technologies, Inc.
11.9 MRM Proteomics Inc.
11.10 Waters Corporation
11.11 GE Healthcare
11.12 Merck KGaA
11.13 Sigma-Aldrich Corp
11.14 Thermo Fisher Scientific Inc.
11.15 Affymetrix Inc.
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Technology 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecasting by Services 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
12.1.5 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 13Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,027.60 - €6,758.66
- INR: ₹180,299.68 - ₹600,998.93
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,736.03 - £5,786.76
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Proteomic is a massive study of proteins of their function and structure of proteome. A proteome is set of proteins produced in an organism which differs from one cell to another cell and changes over time. North America Proteomics Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of XX% to reach USD XX billion by 2024.
North America Proteomics Market Share:
Proteomics market is segmented by technology, services, application, and geography. On basics of technology, the most substantial share is in North America due to the increasing demand for targeted diagnosis and treatment for the betterment of the medical facilities.
North America Proteomics Market Size:
The capacity of microarrays to provide more information from less number of samples, and treating diseases like obesity and cancer has driven the marketplace for proteomics in North America. In the U.S., protein microarray has demand in the market, for about half the market.
North America Proteomics Market Growth:
The market for proteomics are driven by factors such as genetic disorders, pharmaceutical, biopharmaceutical market, advancement in technology, and customised medicines are reasons for the overall growth of the North America proteomics market.
North America Proteomics Market Industrial Analysis:
North America Proteomics Market is segmented by technology, services, applications, and geography. In this classification, the growth of the market is driven by technology segment classified by chromatography, X-Ray crystallography, protein microarray, and spectroscopy. In the forecast period, Asia-Pacific is expected to grow at a quick pace for proteomics technologies.
North America Proteomics Market Outlook:
Proteomics is primarily used to treat the genetic disorders, obesity, cancer and increase in demand for the pharmaceutical research, increased investment by the government for R&D in proteomics, healthcare and drug development further increased the demand for proteomics across various verticals and it’s predominant in North America especially the US.
North America Proteomics Market Trends:
Caprion Bioscience Inc., along with the Foundation for the National Institutes of Health Biomarkers Consortium has come up with the Cerebrospinal Fluid Proteomics project in August 2017.
GE Healthcare Inc., providers of science and medical products, has acquired Puridify Inc., in November 2017.
North America Proteomics Market Research Reports:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Caprion Proteomics Inc.
- PerkinElmer, Inc.
- Bruker Corporation
- Danaher Corporation
- Bio-Rad Laboratories, Inc.
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Protein Microarray
6.2 X-Ray Crystallography
6.3 Chromatography
6.4 Spectroscopy
Chapter 7 Market Segmentation by Services
7.1 Quantitation Services
7.2 Data Analysis & Maintenance
7.3 Analytical Laboratory Services
Chapter 8 Market Segmentation by Application
8.1 Drug Discovery
8.2 Clinical Diagnosis
8.3 Others
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Genzyme Corporation
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 Caprion Proteomics Inc.
11.3 PerkinElmer, Inc.
11.4 Bruker Corporation
11.5 Danaher Corporation
11.6 Bio-Rad Laboratories, Inc.
11.7 Luminex Corporation
11.8 Agilent Technologies, Inc.
11.9 MRM Proteomics Inc.
11.10 Waters Corporation
11.11 GE Healthcare
11.12 Merck KGaA
11.13 Sigma-Aldrich Corp
11.14 Thermo Fisher Scientific Inc.
11.15 Affymetrix Inc.
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Technology 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecasting by Services 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
12.1.5 Market Estimates and Forecasting by Company 2018-2024 (USD Million)
Chapter 13Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.